retatrutide headache Long-Term Side Effects: What Current Trial Data Show – Bolt Pharmacy Retatrutide: Is It The Next

Many people achieve good results with semaglutide

At 9mg weekly: Nausea: 38.1% Diarrhea: 34.7% Constipation: 21.8% Vomiting: approximately 15-20% At 12mg weekly: Nausea: 43.2% Diarrhea: 33.1% Constipation: 25.0% Vomiting: approximately 18-22% These numbers look concerning, but context matters

Retatrutide is not currently licensed by the MHRA for weight loss in the UK, so it cannot legally be prescribed or supplied as an approved weight loss treatment

There may also be some placebo effects here, just from trying to be better in general

From 2021 to 2022, semaglutide went from number 10 to number six on the list of top Medicare Part D drugs by total gross spending

Its not surprising, then, that results from Mercers National Survey of Employer-Sponsored Health Plans 2023 show that fewer than half of large employers (42% of those with 500 or more employees) currently cover GLP-1 medications for treatment of obesity, although another 19% say they are considering it